Pharmaceuticals
Fosun International's FTSE Russell ESG Rating Upgraded and Becomes First-time Constituent of FTSE4Good Index Series
HONG KONG, June 23, 2022 /PRNewswire/ -- The world's leading index company, FTSE Russell, recently announced the latest ESG (Environmental, Social and Governance) rating results of Fosun International Limited (HKEX stock code: 00656) ("Fosun International"). Fosun International's FTSE Russell ESG...
2022-06-23 18:56
5051
Ocumension OT-401 (Product name: YUTIO), a treatment for chronic non-infectious uveitis officially approved for marketing by the National Medical Products Administration
BEIJING, June 23, 2022 /PRNewswire/ -- Ocumension Therapeutics （1477.HK）announced that the New Drug Application (NDA) for the core product in its pipeline, OT-401 (Sterile non-bioerodible intravitreal implant, Product name: YUTIO), was officially approved by the National Pharmaceutical Administ...
2022-06-23 12:19
3399
A Painless, Micro Injection that One Can Do Oneself with the Latest Chula's Innovation "Detachable and Dissolvable Microneedles"
BANGKOK, June 23, 2022 /PRNewswire/ -- A startup under the umbrella of CU Innovation Hub in collaboration with the Chula Faculty of Science has developed an innovative"Detachable and Dissolvable Microneedle" that makes any injections easy and painless for everyone, while also significantly reduci...
2022-06-23 10:00
3494
Sirnaomics to Present the Latest Developments of Dual-Targeted RNAi Therapeutics based on its Proprietary GalAhead™ Program at the 4th Annual RNA Therapeutic: From Concept to Clinic Symposium
GAITHERSBURG, Md. and SUZHOU, China, June 22, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced that the Company's Chief Technology Officer,Dmitry Samarsky, Ph...
2022-06-22 00:29
4057
Apowiser Raises $1.5M In Seed Funding from Longliv Ventures, a Member of CK Hutchison Holdings, to Expand the Global Reach of its Novel Digital Platform that Empowers Consumers to make Informed Choices when Selecting Over-the-Counter Medications
RA'ANANA, Israel, June 21, 2022 /PRNewswire/ -- Apowiser
2022-06-21 19:00
3076
Fosun's Innovative Achievements Continue to Make Breakthroughs
Thanks to its Robust Global Ecosystem, Fosun's Various Business Segments Continue to Achieve Growth HONG KONG, June 21, 2022 /PRNewswire/ -- With the resumption of work, production, and business operations inShanghai, the 4th 515 Fosun Family Day, which has been ongoing for more than a month, us...
2022-06-21 17:04
3851
Nippon Express Launches New Transport Service Using Environment-friendly Isothermal Packaging
-First Japanese Logistics Company to Collaborate with EMBALL'ISO, Experienced in Vaccine Transport- TOKYO, June 21, 2022 /PRNewswire/ -- Nippon Express Co., Ltd., a group company of Nippon Express Holdings, Inc., has become the first Japanese logistics company to collaborate with EMBALL'ISO, a F...
2022-06-21 14:00
3176
Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-Line Treatment for Esophageal Squamous Cell Carcinoma
SAN FRANCISCO, INDIANAPOLIS and SUZHOU, China, June 21, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic, opht...
2022-06-21 08:00
4707
Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis
HONG KONG, June 17, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, is pleased to announce that Cellenkos, Inc. ("CLNK"...
2022-06-17 04:20
4450
Global Pharmaceutical Market Drives Innovative Digitalization to Accelerate Drug Discovery
According to Frost & Sullivan, digitalization across the pharmaceutical value chain will improve the industry´s efficiency. SAN ANTONIO, June 16, 2022 /PRNewswire/ -- Frost & Sullivan's recent analysis, Global Pharmaceuticals Outlook, finds that the accelerated drug development timelines are driv...
2022-06-16 15:12
2591
Sirnaomics Announces Publication of STP705 Clinical Study Results for Treatment of isSCC in the Peer-Reviewed Journal of Drugs in Dermatology
GAITHERSBURG, Md. and SUZHOU, China, June 16, 2022 /PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced the peer-reviewed publication of Phase IIa clinical study results of its lead th...
2022-06-16 13:01
4086
GILEAD SCIENCES NEW DATA HIGHLIGHTS PEOPLE LIVING WITH HIV WHO ARE VIRALLY SUPPRESSED EXPERIENCE SIMILAR HEALTH-RELATED QUALITY OF LIFE AS GENERAL POPULATION
– Data in Taiwan Shows That Antiretroviral Therapies Have Helped Transform HIV Into a Chronic Condition and Bring Positive Change in the Outlook for People Living with HIV– SINGAPORE, June 16, 2022 /PRNewswire/ -- Gilead Sciences, Inc. today announced results from an online survey that assessed ...
2022-06-16 11:15
3030
Ascletis Announces Oral Presentation on Updates from Phase IIb Clinical Trial of ASC22, a Subcutaneous PD-L1 Antibody for Functional Cure of Chronic Hepatitis B at EASL ILC 2022
- The updates of ASC22 Phase IIb study will be presented at the oral session during the International Liver Congress™ 2022 onSaturday, June 25, 2022 at 14:15 , Beijing Time (Abstract Number: OS091) HANGZHOU, China and SHAOXING, China, June 16, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672...
2022-06-16 08:10
4000
Novotech and Medidata expand partnership to continue advancements in clinical research
Leading Asia-Pacific biotech specialist CRO Novotech and Medidata renew partnership, further expanding services to Novotech clients in APAC and the US SINGAPORE, June 16, 2022 /PRNewswire/ -- Medidata, a Dassault Systèmes company, today announced its renewed, expanded partnership with Novotech, a...
2022-06-16 08:00
3439
How Global Healthcare Spending and Regulations Boost the Surgical Gloves Market
Demand for environmentally friendly biodegradable surgical gloves unlocks new opportunities for market participants, says Frost & Sullivan SAN ANTONIO, June 15, 2022 /PRNewswire/ -- The increase in healthcare budgets and rise in the number of surgical procedures propel global surgical gloves mar...
2022-06-15 15:12
2104
Pierre Fabre and Lonza Enter Manufacturing Agreement for W0180 Antibody Drug Product
* Lonza will provide clinical drug product manufacturing for W0180, an oncology drug candidate discovered byPierre Fabre targeting solid tumors, from its fill and finish facility in Stein,Switzerland * Pierre Fabre will leverage Lonza's drug product expertise and fill and finish capabilities ...
2022-06-15 14:30
3062
Telix and Invicro Advance AI Partnership
MELBOURNE, Australia and BOSTON, June 14, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has advanced a partnership with Invicro LLC (Invicro), a global, industry-leading imaging CRO, and part of REALM IDx, Inc., to develop an artificial...
2022-06-14 14:21
3569
Alphamab Oncology Announced First Patient Dosed in Phase I Trial of PD-L1/OX40 Bispecific Antibody KN052
SUZHOU, China, June 14, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient was dosed in a Phase I clinical study (KN052-CHN-001) of KN052, its proprietary PD-L1/OX40 bispecific antibody, in patients with advanced solid tumors inChina. With the developme...
2022-06-14 08:58
5368
Innovent and Etana Jointly Announce the Approval of Bevagen® (Bevacizumab Biosimilar) by the Indonesian Food and Drugs Authority (BPOM)
SAN FRANCISCO and SUZHOU, China, June 14, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...
2022-06-14 08:00
5957
Innovent Announces the NMPA Acceptance of the New Drug Application for Tafolecimab Injection (anti-PCSK-9 antibody)
SAN FRANCISCO and SUZHOU, China, June 14, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...
2022-06-14 08:00
5033
Week's Top Stories
Most Reposted
DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 279 media titles]
2026-10-06 05:28SMU School of Accountancy launches Applied AI Track for next generation of accounting and finance professionals
[Picked up by 279 media titles]
2026-10-07 11:50Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 277 media titles]
2026-10-08 09:50
Vestas Powers Up Vietnam's Clean Energy Ambitions with Two New Projects Under PDP8 Totaling 16 Wind Turbines
[Picked up by 263 media titles]
2026-10-02 16:27
Southeast Asia's China travel map is widening, Traveloka platform data shows
[Picked up by 262 media titles]
2026-10-05 11:51Most Read
MixVio AI Launches Unified Creative Workspace Across 26 AI Generation Routes
2026-10-02 00:30
24436